It was further demonstrated that YQFM reduced the size of myocardial infarction, improved cardiac function, and inhibited the expression of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), NF-κB, IL-6, and interleukin-1β (IL-1β). The gene discussed is TNF; the disease is myocardial infarction.